FineHeart
FineHeart is a clinical-stage medical device company developing innovative cardiac implantable technologies to treat advanced heart failure. The company is focused on FlowMaker®, a fully implantable cardiac output accelerator designed to provide physiological, low-energy support without percutaneous connections, and aims to lead in the European Active Implantable Medical Devices (AIMDs) sector.
Leadership & Board
- Current Number of Employees
- 86
- Current LinkedIn Followers
- 8,190
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $35M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $35M
- Latest Funding Round
- Series C
- Post-Money Valuation
- ―
Company Momentum Positive
FineHeart LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
FineHeart had 86 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
FineHeart had 8,190 followers as of October 12, 2026. The number of followers increased by 27 (0.33%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 08, 2026 | Series C | $35.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Groupe Pasteur Mutualité | Series C |
| Groupe Etchart | Series C |
| European Innovation Council | Series C |
| FH Founders | Series C |
| Lurra | Series C |
| IRDI | Series C |
| Groupe Doliam | Series C |
| NACO | Series C |
Similar Companies
A snapshot of private companies similar to FineHeart, helping you discover and navigate related company profiles.
